-

Imperative Care Launches Ikon 24 Pro Guidewire, Enhancing the Zoom Stroke System to Support More Efficient Stroke Procedures

The First Uniform 0.024” Diameter Wire, Purpose-Built for Stroke

CAMPBELL, Calif.--(BUSINESS WIRE)--Imperative Care, a medical technology company focused on advancing treatments for patients suffering from thromboembolic disease, today announced the launch of the Ikon™ 24 Pro Guidewire, a next-generation neurovascular guidewire purpose-built to improve vascular access during stroke procedures.

“Advances in aspiration thrombectomy over the past decade have created an opportunity to develop a guidewire that better supports today's procedural workflow,” said Jay Martin, Chief Commercial Officer of Imperative Care. “Ikon 24 Pro is the latest addition to our stroke portfolio and reflects Imperative Care’s commitment to innovating every step of the procedure. This advanced neurovascular guidewire was designed to give physicians the support and control needed to confidently treat a broad range of stroke patients.”

Engineered differently from traditional guidewires, Ikon 24 Pro incorporates three core capabilities:

  • The first uniform 0.024” wire: a 0.024” diameter throughout the length of the guidewire, engineered to deliver robust performance and precise control from tip to tail.
  • Progressive support profile: an innovative transitional shaft design, precisely matched to the Zoom Catheters, intended to balance support and flexibility above and below the arch.
  • Precision you can feel: designed to enhance tactile feedback to provide intuitive handling and real-time control at every turn.

Together, these capabilities are intended to give physicians a guidewire designed to enhance the entire stroke system for aspiration thrombectomy. Ikon 24 Pro builds on the same approach behind Imperative Care's Zoom 0.088” intracranial access technology, which has demonstrated physician adoption due to its combination of proximal support for the arch and distal flexibility for navigating tortuous neurovasculature. Ikon 24 Pro is designed to help improve procedural speed and efficiency when paired with the Zoom Stroke System.

“Ikon 24 Pro offers a reliable balance of support and flexibility that is well-suited for acute stroke interventions,” said Kunal Vakharia, MD, University of South Florida, who was among the first physicians to perform patient cases with the guidewire. “In my clinical experience, the wire has provided consistent navigability and excellent control, making my stroke procedures more efficient with the Zoom System.”

About the Zoom Products

The Zoom™ Stroke System is designed to be a complete stroke system from access through reperfusion for fast and effective clot removal in patients presenting with acute ischemic stroke. Imperative Care’s Zoom Stroke System consists of the Zoom 35, 4S, 45, 55, 71 and 7X Catheters, Zoom 88 Large Distal Platform, Zoom 88 Support, Zoom POD and Zoom Aspiration/Zoom POD tubing, Zoom Canister and DuoPort Canister.

All Zoom Catheters are designed with an asymmetric tip, which has been shown to provide 15% greater clot engagement area at the tip of the catheter, relative to a traditional flat-tip catheter,2 and are constructed to enable smooth tracking through challenging vasculature. For complete product information, including indications, contraindications, warnings, precautions and adverse events, visit: https://bit.ly/3yWkfEJ.

About Imperative Care

Imperative Care is a commercial-stage medical technology company focused on advancing treatments for patients suffering from thromboembolic disease, a serious medical condition caused by blood clot formation inside veins and arteries. Imperative Care was founded with the mission of bringing lifesaving treatments to patients suffering from ischemic stroke and other devastating vascular diseases caused by blood clot formation.

The company’s commercially available product portfolio includes the Zoom Stroke System, the Symphony Thrombectomy System, and the Prodigy Thrombectomy System. In addition to its commercial products, Imperative Care is developing the Telos robotic platform,1 an endovascular robotic system designed to bring greater precision and standardization to procedures and expand access to lifesaving treatment.

Imperative Care is based in Campbell, California. Learn more at www.imperativecare.com.

1 Currently in development. Not approved for use or available for sale.

2 Vargas J, Blalock J, Venkatraman A, et al. Efficacy of beveled tip aspiration catheter in mechanical thrombectomy for acute ischemic stroke. J Neurointerv Surg. 2021;13:823-826.

Imperative Care, the Imperative Care logo, Zoom, and Ikon are trademarks or registered trademarks of Imperative Care.

Contacts

Media Contact:
Rigo Magana
Imperative Care
rmagana@imperativecare.com

Investor Contact:
Phil Nalbone
Imperative Care
pnalbone@imperativecare.com

Imperative Care


Release Summary
Imperative Care launches Ikon 24 Pro Guidewire, enhancing the Zoom Stroke System to support more efficient stroke procedures.
Release Versions

Contacts

Media Contact:
Rigo Magana
Imperative Care
rmagana@imperativecare.com

Investor Contact:
Phil Nalbone
Imperative Care
pnalbone@imperativecare.com

More News From Imperative Care

Latest Analysis of Imperative Care’s SYMPHONY-PE Trial Suggests Early Thrombectomy May Improve Key Measures of Heart Recovery in Intermediate-Risk Pulmonary Embolism

CAMPBELL, Calif.--(BUSINESS WIRE)--Latest analysis of Imperative Care’s SYMPHONY-PE trial suggests early thrombectomy may improve key measures of heart recovery in intermediate-risk PE....

Imperative Care Appoints Jay Martin as Chief Commercial Officer

CAMPBELL, Calif.--(BUSINESS WIRE)--Imperative Care appoints Jay Martin as Chief Commercial Officer....

Imperative Care Initiates ADAPT 2.0 Study Evaluating Advanced Clinical Technique Designed to Simplify Acute Ischemic Stroke Treatment

CAMPBELL, Calif.--(BUSINESS WIRE)--Imperative Care, a medical technology company focused on advancing treatments for patients suffering from thromboembolic disease, today announced that initial patients have been enrolled in the ADAPT 2.0 Clinical Study, a prospective, multi-center, open-label, observational study evaluating the effectiveness, safety and clinical outcomes of the ADAPT 2.0 technique using the Zoom Stroke System to treat patients with acute ischemic stroke. “This study is designe...
Back to Newsroom